These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6184702)

  • 1. A fragment of substance P with specific central activity: SP(1-7).
    Stewart JM; Hall ME; Harkins J; Frederickson RC; Terenius L; Hökfelt T; Krivoy WA
    Peptides; 1982; 3(5):851-7. PubMed ID: 6184702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of isolation-induced fighting by N- and C-terminal analogs of substance P: evidence for multiple recognition sites.
    Hall ME; Stewart JM
    Peptides; 1984; 5(1):85-9. PubMed ID: 6200867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats.
    Tschöpe C; Jost N; Unger T; Culman J
    Brain Res; 1995 Aug; 690(1):15-24. PubMed ID: 7496802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
    Hall ME; Grantham P; Limoli J; Stewart JM
    Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of substance P and its fragments: analgesic properties, effect on behavior and monoaminergic processes].
    Klusha VE; Abissova NA; Mutsenietse RK; Svirskis ShV; Binert M
    Biull Eksp Biol Med; 1981 Dec; 92(12):692-4. PubMed ID: 6173081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P.
    Velázquez RA; McCarson KE; Cai Y; Kovács KJ; Shi Q; Evensjö M; Larson AA
    Eur J Neurosci; 2002 Jul; 16(2):229-41. PubMed ID: 12169105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P N-terminal metabolites and nitric oxide mediate capsaicin-induced antinociception in the adult mouse.
    Kreeger JS; Kitto KF; Larson AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1281-5. PubMed ID: 7527854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord.
    Yukhananov RYu ; Larson AA
    Neurosci Lett; 1994 Aug; 178(1):163-6. PubMed ID: 7529387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal exposure to substance P alters behavioral and substance P levels in the central nervous system of the adult rat.
    Meyerson BJ; Blomqvist A; Ericson AC; Le Grevés P
    Brain Res Dev Brain Res; 1991 Apr; 59(2):163-70. PubMed ID: 1717177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptors.
    De Araújo JE; Huston JP; Brandão ML
    Peptides; 2001 Sep; 22(9):1447-52. PubMed ID: 11514027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N- and C-terminal fragments of substance P: spinal effects in the rat tail flick test.
    Cridland RA; Henry JL
    Brain Res Bull; 1988 Apr; 20(4):429-32. PubMed ID: 2456135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of blood pressure by substance P: opposite effects of N- and C- terminal fragments on anesthetized rats.
    Hall ME; Miley FB; Stewart JM
    Life Sci; 1987 May; 40(19):1909-14. PubMed ID: 2437424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain.
    Goettl VM; Larson AA
    Neuroscience; 1994 May; 60(2):375-82. PubMed ID: 7521022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of substance P transport across the blood-brain barrier.
    Chappa AK; Audus KL; Lunte SM
    Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality.
    Fransson R; Botros M; Nyberg F; Lindeberg G; Sandström A; Hallberg M
    Neuropeptides; 2008 Feb; 42(1):31-7. PubMed ID: 18093649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid and neurokinin activities of substance P fragments and their analogs.
    Lei SZ; Lipkowski AW; Wilcox GL
    Eur J Pharmacol; 1991 Feb; 193(2):209-15. PubMed ID: 1710992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons.
    Tang HB; Li YS; Arihiro K; Nakata Y
    Mol Pain; 2007 Dec; 3():42. PubMed ID: 18157919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressor effects of substance P and C-terminal sequences after intracisternal injection to alpha-chloralose-anaesthetized rats: blockade by a substance P antagonist.
    Fuxe K; Agnati LF; Rosell S; Härfstrand A; Folkers K; Lundberg JM; Andersson K; Hökfelt T
    Eur J Pharmacol; 1982 Jan; 77(2-3):171-6. PubMed ID: 6174354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats.
    Zhou Q; Carlsson A; Botros M; Fransson R; Sandström A; Gordh T; Hallberg M; Nyberg F
    Peptides; 2009 Dec; 30(12):2418-22. PubMed ID: 19686790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.